The APX/GPX expression is highly associated with the metabolic state of the cells
10.1007/s40618-020-01455-7 72 IDF (2021)
What happens if I stop taking tirzepatide As demonstrated in the SURMOUNT-4 clinical trial, discontinuing tirzepatide without an ongoing management plan typically results in partial weight regain over time
What side effects should I actually expect
See my options Editorial update What to know before deciding Updated Jul 21, 2026 Blue Cross Weight Loss Medication Coverage depends on the specific formulary, employer or state plan, diagnosis criteria, prior authorization, and sometimes step therapynot only the insurer name
In future RCTs, key considerations such as the optimal timing of intervention, treatment duration, specific patient subgroups based on molecular diagnosis, and potential systemic adverse events require further investigation